Fengjuan X. Huang

Zhengzhou, 450052, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications

Development and validation of a predictive model for hypothalamic obesity following craniopharyngioma resection.

Development and validation of a predictive model for hypothalamic obesity following craniopharyngioma resection.

Journal: BMC endocrine disorders
Published: February 23, 2026

Metformin alleviates renal tubular injury in diabetic kidney disease by activating mitophagy and inhibiting ferroptosis via HIF-1α/MIOX axis.

Metformin alleviates renal tubular injury in diabetic kidney disease by activating mitophagy and inhibiting ferroptosis via HIF-1α/MIOX axis.

Journal: Journal of pharmaceutical analysis
Published: September 10, 2024

Targeting ferroptosis as a prospective therapeutic approach for diabetic nephropathy.

Targeting ferroptosis as a prospective therapeutic approach for diabetic nephropathy.

Journal: Annals of medicine
Published: April 24, 2024

The role of metabolic memory in diabetic kidney disease: identification of key genes and therapeutic targets.

The role of metabolic memory in diabetic kidney disease: identification of key genes and therapeutic targets.

Journal: Frontiers in pharmacology
Published: January 31, 2024

Associations between life's essential 8 and metabolic health among us adults: insights of NHANES from 2005 to 2018.

Associations between life's essential 8 and metabolic health among us adults: insights of NHANES from 2005 to 2018.

Journal: Acta diabetologica
Published: January 18, 2024

Upregulation of UHRF1 Promotes PINK1-mediated Mitophagy to Alleviates Ferroptosis in Diabetic Nephropathy.

Upregulation of UHRF1 Promotes PINK1-mediated Mitophagy to Alleviates Ferroptosis in Diabetic Nephropathy.

Journal: Inflammation
Published: August 11, 2023

LncRNA H19: a novel player in the regulation of diabetic kidney disease.

LncRNA H19: a novel player in the regulation of diabetic kidney disease.

Journal: Frontiers in endocrinology
Published: June 12, 2023

SUMO specific peptidase 6 regulates the crosstalk between podocytes and glomerular endothelial cells in diabetic kidney disease.

SUMO specific peptidase 6 regulates the crosstalk between podocytes and glomerular endothelial cells in diabetic kidney disease.

Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: December 07, 2022

Development and validation of a nomogram to estimate future risk of type 2 diabetes mellitus in adults with metabolic syndrome: prospective cohort study.

Development and validation of a nomogram to estimate future risk of type 2 diabetes mellitus in adults with metabolic syndrome: prospective cohort study.

Journal: Endocrine
Published: October 03, 2022

Identification of circular RNAs and functional competing endogenous RNA networks in human proximal tubular epithelial cells treated with sodium-glucose cotransporter 2 inhibitor dapagliflozin in diabetic kidney disease.

Identification of circular RNAs and functional competing endogenous RNA networks in human proximal tubular epithelial cells treated with sodium-glucose cotransporter 2 inhibitor dapagliflozin in diabetic kidney disease.

Journal: Bioengineered
Published: February 07, 2022

Renal outcomes and prognostic factors in patients with type-2 diabetes and chronic kidney disease confirmed by renal biopsy.

Renal outcomes and prognostic factors in patients with type-2 diabetes and chronic kidney disease confirmed by renal biopsy.

Journal: Therapeutic advances in chronic disease
Published: May 07, 2021

FoxO1-mediated inhibition of STAT1 alleviates tubulointerstitial fibrosis and tubule apoptosis in diabetic kidney disease.

FoxO1-mediated inhibition of STAT1 alleviates tubulointerstitial fibrosis and tubule apoptosis in diabetic kidney disease.

Journal: EBioMedicine
Published: July 31, 2019
Showing 1-12 of 26

Last Updated: 09/26/2026